CVS HEALTH CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
CVS HEALTH CORPORATION (CVS) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $204.00 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2026-02-10
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $204.00M.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $164.00M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $108.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2025-12-31 | $204.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $164.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $108.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |